NewGenIvf Group Limited

NASDAQ: NIVF · Real-Time Price · USD
1.89
-0.03 (-1.56%)
At close: Aug 15, 2025, 3:59 PM
1.86
-1.59%
After-hours: Aug 15, 2025, 07:47 PM EDT

NewGenIvf Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2024 Q3 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q3 2021 Q2 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Sep 30, 2021 May 31, 2021
Revenue
4.27M 2.99M 1.52M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
3.06M 2.15M 1.32M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
1.2M 843.03K 196.82K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-2.52M -1.79M -2.52M -1.37M -1.1M -855.42K -504.91K -389.35K -284.81K -162.12K -2.09K -2.01K
Interest Income
509.41K 957.36K 1.52M 2.11M 1.92M 1.56M 1.01M 415.56K 100.68K 6.53K n/a n/a
Pretax Income
-1.4M -772.82K -690.36K 739K 820.3K 706.27K 500.65K 26.21K -184.13K -155.59K -2.09K -2.01K
Net Income
-955.84K -762.34K -690.36K 739K 820.3K 706.27K 501.15K 26.71K -183.63K -155.09K -2.09K -2.01K
Selling & General & Admin
3.52M 2.44M 2.52M 1.37M 1.1M 855.42K 504.91K 389.35K 284.81K 162.12K 2.09K 2.01K
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
3.52M 2.44M 2.52M 1.37M 1.1M 855.42K 504.91K 389.35K 284.81K 162.12K 2.09K 2.01K
Interest Expense
694.27K 273.17K 25.26K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
5.26M 3.27M 2.52M 1.37M 1.1M 855.42K 504.91K 389.35K 284.81K 162.12K 2.09K 2.01K
Income Tax Expense
-487K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
569.25K 363.65K 253.73K 135.54K 135.54K 135.54K 217.35K 217.35K 217.35K 135.54K 37.5M 37.5M
Shares Outstanding (Diluted)
569.25K 363.65K 253.73K 135.54K 135.54K 135.54K 217.35K 217.35K 217.35K 135.54K 37.5M 37.5M
EPS (Basic)
50.40 70.90 81.85 103.35 103.85 84.80 46.90 -7.65 -31.6 -28.3 -0.00 -0.00
EPS (Diluted)
50.40 70.90 81.85 103.35 103.85 84.80 46.90 -7.65 -31.6 -28.3 -0.00 -0.00
EBITDA
864.07K 891.23K 716.48K 739K 820.3K 706.27K 501.15K 26.71K -183.63K -155.09K -2.09K -2.01K
EBIT
507.91K 714.99K 549.53K 739K 820.3K 706.27K 501.15K 26.71K -183.63K -155.09K -2.09K -2.01K
Depreciation & Amortization
356.15K 176.25K 166.95K n/a n/a n/a n/a n/a n/a n/a n/a n/a